April 28, 2023 by admin aurigene Novel, potent and orally bioavailable small molecule CD73 inhibitors for cancer immunotherapy
April 28, 2023 by admin aurigene Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders
April 28, 2023 by admin aurigene Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
April 28, 2023 by admin aurigene Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action
April 28, 2023 by admin aurigene Discovery of orally bioavailable SMARCA2/4 dual degraders for treatment of acute myeloid leukemia
April 28, 2023 by admin aurigene Evaluation of AU-18069, a novel small molecule CBP/p300 bromodomain inhibitor for the treatment of cancers
April 28, 2023 by admin aurigene AUR103 an oral small molecule CD47 antagonist in combination with azacytidine and bortezomib exhibits potent anti-tumor activity in myeloma and leukemia models in vitro
